Pittsburgh, PA, United States of America

Paul David Robbins

This inventor holds 20 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in Gene Therapy. Top assignees: University of Pittsburgh, Scripps Research Institute, Other. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul David Robbins. Retrieved from https://idiyas.com/inventor/paul-david-robbins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 95.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 278(Granted Patents)

Location History:

Mt. Lebanon, PA (US) (2003 - 2007)
Pittsburgh, PA (US) (1998 - 2020)
Juno Beach, FL (US) (2016 - 2020)

Company Filing History:

18 out of 1,963

University of Pittsburgh

patents

1 out of 1,208

Scripps Research Institute

patents

1 out of 834,601

Other

patents

Years Active: 1998-2020

Loading Chart...

Areas of Expertise:

Gene Therapy

Stem Cell Rejuvenation

Degenerative Disorders

Cardiac Proteins

Polypeptides

Viral Vectors

Transgene Delivery

Tolerogenic Cells

Mutant CFTR

Retroviral Vectors

Connective Tissue

Chondrocytes

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10758522 - Small molecule analogs of the nemo binding peptide (2020-09-01),

2. 10751273 - Compounds for the treatment of pathologies associated with aging and degenerative disorders (2020-08-25),

3. 10293001 - Compositions and methods for restoring or rejuvenating stem/progenitor cell function (2019-05-21),

4. 9295696 - Compositions and methods for restoring or rejuvenating stem/progenitor cell function (2016-03-29),

5. 9249184 - Cardiac-specific protein targeting domain (2016-02-02),

6. 9220711 - Compounds for the treatment of pathologies associated with aging and degenerative disorders (2015-12-29),

7. 8937086 - Compounds for the treatment of pathologies associated with aging and degenerative disorders (2015-01-20),

8. 7264948 - Polypeptides for increasing mutant CFTR channel activity (2007-09-04),

9. 7105494 - Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies (2006-09-12),

10. 7037492 - Gene transfer for studying and treating a connective tissue of a mammalian host (2006-05-02),

11. 6936468 - Use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same (2005-08-30),

12. 6881825 - Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues (2005-04-19),

13. 6544771 - Retroviral gene therapy vectors and therapeutic methods based thereon (2003-04-08),

14. 6413511 - Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide (2002-07-02),

15. 6228356 - Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints (2001-05-08),

Title: Innovations by Paul David Robbins in the Field of Biomedical Research

Introduction

Paul David Robbins, located in Pittsburgh, PA, has made significant contributions to biomedical research through his innovative work and patents. With a total of 20 patents to his name, Robbins focuses on advancing treatments for various medical conditions, showcasing his dedication to improving health outcomes.

Latest Patents

Robbins' latest patents include groundbreaking inventions aimed at treating a range of conditions. One of his notable patents involves small molecule analogs of the NEMO binding peptide. This invention includes a method for inhibiting the interaction between NF-κB essential modulator (NEMO) and IκB kinase-β (IKK-β) within living cells. By exposing cells to effective concentrations of NEMO-binding domain analogs, this method has the potential to treat conditions such as muscular dystrophy, asthma, inflammatory bowel disease, multiple sclerosis, Parkinson's disease, arthritis, diabetes, and various age-related pathologies.

Another significant patent from Robbins focuses on compounds for treating pathologies associated with aging and degenerative disorders. This invention outlines methods for reducing the signs of aging or degenerative disorders in individuals, emphasizing the importance of delaying onset, slowing progression, and reducing severity. The compounds proposed in this patent represent a promising avenue for combating the effects of aging.

Career Highlights

Throughout his career, Paul David Robbins has worked at prestigious institutions, including the University of Pittsburgh. His research has not only contributed to scientific knowledge but also resulted in tangible innovations that hold promise for addressing pressing health challenges.

Collaborations

Robbins has collaborated with notable coworkers such as Christopher H. Evans and Joseph C. Glorioso. These collaborations highlight the collective effort within the research community to translate innovative ideas into practical solutions that improve patient outcomes.

Conclusion

Paul David Robbins exemplifies the spirit of innovation in the biomedical field. Through his extensive patent portfolio and collaborations with esteemed colleagues, he continues to influence the landscape of medical research and treatment. His work promises to lead to significant advancements in health care, benefiting countless individuals in need of effective medical interventions.

Profile summary based on public USPTO records.